	流动资产		日
Acadia Pharmaceuticals	USD 1.1B	33.9M	2026-03
Adma Biologics	USD 511.17M	44.66M	2026-03
ALKERMES	USD 1.36B	570.52M	2026-03
Alterity Therapeutics Limited	AUD 37.91M	15.92M	2025-12
AstraZeneca	USD 29.61B	890M	2026-03
BioCryst Pharmaceuticals	USD 373.62M	30.72M	2026-03
Bristol-Myers Squibb	USD 27.21B	2.18B	2026-03
Cipla	INR 241.47B	7.71B	2026-03
Clal Biotechnology	ILS 14.69M	1.95M	2023-12
Compugen	USD 137.28M	10.74M	2026-03
CSL	USD 11.85B	1000K	2025-12
Eli Lilly	USD 54.84B	794M	2026-03
Esperion Therapeutics	USD 459.46M	3.11M	2026-03
GlaxoSmithKline	GBP 17.76B	251M	2026-03
Grifols	EUR 5.96B	316.31M	2025-12
Halozyme Therapeutics	USD 1B	177.83M	2026-03
Ionis Pharmaceuticals	USD 2.94B	52M	2026-03
J&J	USD 59.17B	3.55B	2026-03
Merck	USD 35.02B	8.5B	2026-03
Minerva Neurosciences	USD 83.1M	70.08M	2025-12
Neurocrine Biosciences	USD 2.44B	86.6M	2026-03
Novartis	USD 26.61B	3.85B	2026-03
Novavax	USD 850.82M	127.46M	2026-03
Pfizer	USD 42.82B	76M	2026-03
Roche Holding	CHF 38.73B	3.03B	2025-12
Sanofi	EUR 30.16B	789M	2026-03
Takeda	JPY 3.09T	25.94B	2026-03
Vanda Pharmaceuticals	USD 347.26M	20.23M	2025-12